Asia Pacific Lung Cancer Surgery Market Research Report – Segmented By Procedure, Device, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Share, Size, Growth, Trends, Forecast (2024 to 2029)

Updated On: January, 2024
ID: 1898
Pages: 133

APAC Lung Cancer Surgery Market Size (2022 to 2027)

The size of the Lung Cancer Surgery Market in the Asia Pacific has been estimated at USD 6.61 billion in 2022 and is projected to reach USD 10.16 billion by 2027, growing at a CAGR of 9% from 2022 to 2027.

Lung Cancer is a kind of cancer that starts in Lung tissue or its surrounding parts. There are various types of treatments available to treat cancer like Chemotherapy, Radiotherapy, Laser Therapy, and Surgery. Surgery involves the removal of an infected parts from the lungs. In some cases, surgery will be used with other treatment methods to cure cancer. Surgery is only used if cancer cells don’t spread very near to the heart.

Rising pollution levels, an increasing number of cigarette smokers, rising incidence and prevalence of Lung Cancer and rising geriatric population are some of the major factors driving the market.

However, the high cost of Lung Cancer surgery is restraining the growth of the market.

This research report on the Asia Pacific Lung Cancer Surgery Market has been segmented & sub-segmented into the following categories:

By Procedure: 

  • Thoracotomy
    • Lobectomy
    • Pneumonectomy
    • Sleeve Resection
    • Segmentectomy
  • Minimally Invasive

By Device: 

  • Surgical
    • Clamps
    • Forceps
    • Retractors
    • Staplers
    • Cutters
    • Scissors
    • Elevators
    • RIB Sheers
    • Trocars
  • Monitoring
    • Cameras
    • Video Support
  • Visualizing Systems
    • Endoscopic Trocars with optical views
    • Endo surgical Equipment

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

On the basis of procedure, the Minimally Invasive surgeries are expected to grow at the highest CAGR owing to the rising awareness among people for early detection of lung cancer and the advantages of Minimally Invasive Surgeries over conventional surgeries.

On the basis of the device, the Surgical Instruments segment is expected to dominate the market owing to the shorter lifespan of devices and wider adoption of these devices.

Geographically, Europe has the second-largest market after North America owing to its Advanced Healthcare facilities and higher awareness among people and greater economic stability.

Notable companies dominating the Asia Pacific Lung Cancer Surgery Market include Ethicon US LLC, Intuitive Surgical Inc., AngioDynamics Inc., Olympus Corporation, Accuray Inc., Ackermann Instrumente GmbH, Teleflex Inc., KARL STORZ GmbH, Scanlan International Inc., and Trokamed GmbH.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample